午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
ChemicalBook
Beijing Biosynthesis Biotechnology Co Ltd 企業(yè)の連絡(luò)先情報
名前:
Beijing Biosynthesis Biotechnology Co Ltd
電話番號:
400-9019800
電子メール:
sales@bioss.com.cn
國籍:
China
ウェブサイト:
www.biosschina.com
商品の合計數(shù):
6102
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
製品カタログ
PPP2R5D
SCD
ビスステアリン酸カドミウム
C18H36CdO2
ABLIM1
TLE4
STIL
ジエチルスチルベストロール
C18H20O2
Connexin 26
phospho-Ku70 / XRCC6 (Ser5)
Kindlin 2
FOG1
TIE1
SIRT5
CT054
TSPAN13
PAFAH2
Cathepsin S
CLCA4
TNNI3
Ataxin 7
CD85c
LTB4-R1
IL36 gamma
Phosphor-PPP3CA (Ser469)
NXN
PEF1
MATH1
SDS/Serine dehydratase
NOXA2
DNA Polymerase epsilon p59
Phospho-MEK6 (Ser202)
CDK9
IMMP2L
HCN4
CGRP-1/2
XRCC4
HSPA12B
ZP1
ZINPYR-1
C46H36Cl2N6O5
phospho-APC1 (Ser377)
RBM47
CCDC34
Recombinant Human ACSL4 Protein, N-His
phospho-Munc18-1 (Thr574)
MLH1
Histone H3 (Acetyl-Lys9/14) Antibody Blocking Peptide
GORASP2 Antibody Blocking Peptide
EMP-1
チミジル酸
C10H15N2O8P
CEBP Beta
IQGAP3
TNFSF13
4月 ヒト
CROT
MED19/LCMR1
Histone H3 (tri methyl K79)
DEFA1/alpha Defensin 1
PCDHA1 Antibody Blocking Peptide
KCNQ5
EMILIN1
SCARF2
Escherichia coli O157:H7 protein
OLFML2A
Phospho-MARCKS (Ser152 + Ser156)
PATZ1
SNAP25
SCE1 Antibody Blocking Peptide
PPAP2A
SHANK2
MUC12
AKR1A1 Antibody Blocking Peptide
Alpha casein
HTRA2
O-メチルイソ尿素 硫酸塩
C4H14N4O6S
SOX1
MCP4
ASB10
CNN1
APOBEC3B
SLC2A4RG
TRIM21
ZDHHC-12
RETREG1 Antibody Blocking Peptide
Polycystin 1
MCART1
phospho-PKC Epsilon (Ser729)
CtIP
SHB
C11H9NO5
AF10
GHRH
C219H365N73O66S1
14-3-3 beta
Opn1mw
INCA1 Antibody Blocking Peptide
SHANK3
STUB1
CNOT8
Recombinant Human CENPH Protein, N-His
Phospho-CDK1 (Tyr15)
DELE
eIF4EBP1
IL-2R gamma
COX1/MTCO1
PCDHA1
Cytochrome C
チトクロームC (牛の心臓)
C42H52FeN8O6S2
RASGEF1A
PP2CA
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
Copyright 2017 ? ChemicalBook. All rights reserved